BDNF Participates in Chronic Constriction Injury-Induced Neuropathic Pain via Transcriptionally Activating P2X7 in Primary Sensory Neurons

Yi Wu,Zhiwen Shen,Hui Xu,Kun Zhang,Mingyan Guo,Fei Wang,Junhua Li

DOI: https://doi.org/10.1007/s12035-021-02410-0

IF: 5.682

2021-05-07

Molecular Neurobiology

Abstract:Neuropathic pain, resulting from the pathological changes of the somatosensory nervous system, remains a severe public health problem worldwide. The effect of treatment targeting neuropathic pain is very limited, as the underlying mechanism of neuropathic pain is largely unknown. In this study, we demonstrated that the expression level of brain-derived neurotrophic factor (BDNF) was remarkably and time-dependently increased in dorsal root ganglion (DRG) neurons. DRG microinjection of BDNF siRNA in DRG ameliorated chronic constriction injury (CCI) induced mechanical, thermal, and cold nociceptive hypersensitivities. Overexpressing BDNF through microinjection of the AAV5-BDNF in DRG caused enhanced responses to basal mechanical, thermal, and cold stimuli in mice exposed to CCI. Mechanically, the P2X₇ promoter activity was enhanced by CCI-induced increase of DRG BDNF protein and was involved in the CCI-induced upregulation of DRG P2X₇ protein. The overexpression of BDNF also increased P2X₇ expression in DRG neurons, which was validated in in vivo and in vitro experiments. BDNF may exert crucial effect via transcriptionally activating the P2X₇ gene in primary sensory neurons, since P2X₇ acts as a role of endogenous agitator in neuropathic pain and BDNF largely co-expresses with P2X₇ in DRG neurons. Therefore, our data provide evidence that BDNF may be a promising therapeutic target for neuropathic pain.

neurosciences

What problem does this paper attempt to address?

The paper aims to explore the mechanism of brain-derived neurotrophic factor (BDNF) in neuropathic pain induced by chronic constriction injury (CCI). The study found that CCI leads to a significant increase in BDNF expression in dorsal root ganglion (DRG) neurons, and this increase is associated with pain behavioral manifestations. Intrathecal injection of BDNF small interfering RNA (siRNA) into the DRG can alleviate mechanical, thermal, and cold hyperalgesia induced by CCI. Additionally, overexpression of BDNF exacerbates these symptoms. Mechanistically, the study demonstrates that BDNF promotes the development of neuropathic pain by transcriptionally activating the P2X7 receptor gene. Therefore, BDNF may be a potential target for the treatment of neuropathic pain.